U.S. Health Care REITs Stock News

Amneal Pharmaceuticals announced that it received U.S. FDA approval for its iohexol injection, the first generic version of GE Healthcare's Omnipaque, with launch targeted for early 2026 in the U.S. market. This approval allows Amneal to enter a significant segment with estimated annual U.S. sales of approximately US$652 million for iohexol injection products. Next, we'll explore how Amneal's FDA approval for a major generic injectable could impact its earnings outlook and market...

Earlier this month, Zebra Technologies released findings from its 18th Annual Global Shopper Study, highlighting the growing adoption of generative AI, automation, and RFID in retail loss prevention and inventory management, alongside the launch of new advanced inventory and retail media solutions. The study revealed consecutive declines in shopper satisfaction, with inventory challenges remaining a key concern, even as retailers increase investments in real-time tracking and digital...

Ever wondered whether CureVac's stock is a hidden gem or a value trap? You're not alone as many investors are taking a closer look after a wild ride. Despite a turbulent three-year stretch, CureVac shares are up an eye-popping 107.9% in the past year, with a year-to-date gain of 53% sparking new optimism and debate about its outlook. Recent attention around CureVac has centered on developments in its mRNA vaccine research as well as fresh updates on ongoing clinical trials. These...

Barrick Mining (NYSE:B) has seen its stock rise steadily over the past month, gaining 7%. With reliable annual revenue and net income growth, investors are taking a closer look at what factors could drive its performance next. See our latest analysis for Barrick Mining. Barrick Mining’s momentum has clearly shifted gears, with a 53.65% 90-day share price return pointing to renewed investor confidence. Over the past year, total shareholder returns came in at 127.43%, highlighting that...

Jackson Financial (NYSE:JXN) just posted third quarter results that caught investors' attention, moving from a sizable loss last year to a solid net profit. Alongside the earnings, the company announced new dividends and an update to its share buyback efforts. See our latest analysis for Jackson Financial. After a rocky start to the year, Jackson Financial’s momentum is showing signs of a comeback. The latest announcements appear to have reinvigorated investor sentiment, with the stock...

CVB Financial (CVBF) stock has caught the eye of investors lately, with shares showing a mix of moves over the past month. The bank’s recent performance points to shifting sentiment in the sector. See our latest analysis for CVB Financial. Shares of CVB Financial have dipped in 2024, reflecting a 9.5% decline in the year-to-date share price and a 12.8% drop in total shareholder return over the past year. While the company has managed steady long-term growth, recent momentum has faded as...

Crescent Energy Company released its third quarter and nine-month earnings results, reporting third-quarter revenue of US$866.58 million and a net loss of US$9.51 million, while nine-month revenue reached US$2.71 billion with net income of US$141.57 million. An interesting detail from the announcement is that, despite a quarterly net loss, Crescent Energy achieved substantial year-over-year revenue growth and turned a profit over the nine-month period, highlighting improved financial...

In recent days, Cheniere Energy received reaffirmed positive ratings from several major analysts, along with new insider share purchases by company leadership, underscoring confidence in the company's outlook within the LNG sector. Interest in Cheniere was further supported by management’s forecast that U.S. LNG plants could see significant consumption growth, highlighting robust expectations for future demand in the market. We'll look at how analyst confidence and recent insider buying...

Central Bancompany has announced the launch of its initial public offering, offering 17,778,000 Class A shares at an expected price range of US$21.00 to US$24.00 per share, and will apply to list on the Nasdaq Global Select Market under the symbol CBC. This move is distinctive as regional bank IPOs are uncommon in the U.S., underscoring both the company's regional scale and heightened investor interest in financial-services listings. We'll explore how Central Bancompany's planned Nasdaq...

In November 2025, Li Auto announced it selected Hesai Technology as the exclusive lidar supplier for all models in its next-generation assisted driving platform, covering the "L" Series, "i" Series, and "MEGA." This milestone partnership coincided with Hesai Group reporting significant revenue and profitability improvements for the third quarter and releasing upbeat guidance, underscoring accelerating momentum in automotive lidar adoption. We'll explore how becoming Li Auto's exclusive lidar...

Opendoor Technologies is in the spotlight as a wave of investor interest follows its appointment of a new CEO, a push into AI-driven strategy, insider share purchases, and fresh shareholder-friendly initiatives such as tradable warrant dividends. See our latest analysis for Opendoor Technologies. Riding a 410% year-to-date share price return, Opendoor Technologies has delivered one of the market’s strongest rallies. Momentum has been fueled by insider buying, a headline-grabbing CEO...

Assurant, Inc. recently authorized a substantial new US$700 million share repurchase program while also announcing a quarterly dividend of US$0.88 per share, following its third-quarter results showing higher revenue and net income compared to the previous year. This combination of enhanced capital returns and improved financial performance highlights Assurant's focus on shareholder value and operational progress. We'll examine how the approval of a major share repurchase program may...

Taboola.com Ltd. recently reported its third quarter 2025 earnings, showing sales of US$496.76 million and a net income of US$5.24 million, reversing a net loss from the previous year, and also raised its full-year 2025 revenue guidance to a range of US$1.91 billion to US$1.93 billion. This positive shift in profitability and management’s upward revision of revenue outlook highlights improving operational performance and growing confidence in near-term business prospects. With management...

In recent days, Magnolia Oil & Gas reported strong third quarter results featuring record production growth, disciplined capital management, and plans to expand its Giddings field, while Director Ralph Lewis Ropp increased his stake by purchasing 4,500 shares. This combination of operational achievement and insider investment signals continued executive confidence despite a softer oil price environment. We will explore how Director Ropp's share purchase and Magnolia’s robust Q3 operational...

LGI Homes, Inc. recently announced third quarter 2025 results, reporting net income of US$19.7 million and diluted earnings per share of US$0.85, both considerably lower than the same period last year; for the nine months ended September 30, net income was US$55.23 million with diluted EPS of US$2.37, also down from a year ago. The company also issued new guidance for the fourth quarter, projecting between 1,300 and 1,500 home closings with an average sales price per home between US$365,000...

Establishment Labs Holdings Inc. recently reported third-quarter 2025 results, posting revenue of US$53.78 million, up from US$40.23 million a year earlier, while net loss narrowed to US$11.15 million from US$16.68 million year-over-year. The company also raised its 2025 revenue guidance to exceed US$210 million, reflecting management’s confidence in continued sales growth and improving profitability. We will explore how management’s upward revision of annual revenue guidance impacts the...

Illumina (ILMN) is back in the spotlight after the publication of a groundbreaking whole-genome sequencing study in Nature and the Chinese export ban on its products was officially lifted, though requirements remain in place. See our latest analysis for Illumina. Alongside these scientific breakthroughs and improved market access, Illumina’s stock has staged a dramatic recovery, posting a 29.75% gain in share price over the past month and climbing 20.54% in the last quarter. While momentum is...

Applied Digital (APLD) has seen a wave of interest after a period of sharp swings in its stock price. Investors are watching closely to see what is behind this volatility and where the company could be heading next. See our latest analysis for Applied Digital. Despite a turbulent month, Applied Digital’s share price has soared 203% year-to-date and delivered a staggering 227% total shareholder return over the past year. This signals that momentum, while volatile, remains strong as investors...

Turning Point Brands announced strong third-quarter results with US$118.98 million in sales and US$21.08 million in net income, alongside a regular quarterly dividend declaration and expanded share buyback authorization. The company also raised its full-year sales guidance for its Modern Oral product segment, highlighting significant momentum in this fast-growing category. We'll explore how the raised Modern Oral sales outlook and increased buyback authorization could shape Turning Point...

In early November 2025, Omega Healthcare Investors completed an at-the-market follow-on equity offering, raising approximately US$709.92 million by issuing over 16 million shares of common stock at various prices and discounts. This substantial capital raise not only increases the company's financial flexibility, but also has implications for its capital structure and share count going forward. We'll explore how this recently completed equity offering could influence Omega's future growth,...

Warrior Met Coal, Inc. recently reported third quarter 2025 results, showing revenues of US$328.59 million and net income of US$36.6 million, with sales and earnings per share slightly lower than the prior year but generally flat in overall sales performance. In tandem with earnings, the company raised its 2025 full-year guidance for both production and sales volumes by approximately 10%, reflecting management’s confidence in improved operational capabilities for the year. Next, we’ll...

Kohl's (KSS) shares have drawn attention recently, as investors mull over the company’s latest stock movement and recent financial trends. With the retail sector in focus, Kohl’s price action offers plenty to unpack for market watchers. See our latest analysis for Kohl's. After a strong run over the past quarter, Kohl’s 21.6% 90-day share price return has caught the attention of investors, especially given earlier volatility in the retail sector. Despite noticeable short-term momentum and a...

Taysha Gene Therapies (TSHA) released a string of updates, including the arrival of a new Chief Commercial Officer, its latest third quarter financials, and a $200 million shelf registration filing that suggests capital-raising moves could be on the horizon. See our latest analysis for Taysha Gene Therapies. After a series of high-profile updates this quarter, Taysha Gene Therapies’ stock has reflected shifting investor sentiment. Despite a recent dip, the 90-day share price return sits at...

Wondering if Hims & Hers Health is a hidden gem or just generating buzz? Let’s dig into what’s driving all the talk about its value. This stock has delivered a 46.7% gain year-to-date and a whopping 91.4% in the past year, but it has seen some turbulence lately, dropping 41.1% over the past month. Part of these rapid price moves stems from recent headlines, including the company’s expansion into new telehealth categories and partnerships with retail pharmacies. Investors are weighing whether...